153810-37-8 Usage
General Description
2-(Benzo[d]oxazol-5-yl)acetic acid, also known as 2-(5-oxo-2,3-dihydro-1,3-oxazol-2-yl)acetic acid, is a chemical compound with the molecular formula C9H7NO4. It belongs to the class of oxazoles, which are five-membered aromatic heterocycles containing one oxygen and one nitrogen atom. 2-(Benzo[d]oxazol-5-yl)acetic acid has been studied for its potential pharmacological activities, such as anti-inflammatory and analgesic properties. It can also be used as a building block in the synthesis of various organic compounds and pharmaceuticals. Additionally, 2-(Benzo[d]oxazol-5-yl)acetic acid has been found to exhibit fluorescent properties, making it useful in fluorescent labeling and imaging techniques in biological and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 153810-37-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,8,1 and 0 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 153810-37:
(8*1)+(7*5)+(6*3)+(5*8)+(4*1)+(3*0)+(2*3)+(1*7)=118
118 % 10 = 8
So 153810-37-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H7NO3/c11-9(12)4-6-1-2-8-7(3-6)10-5-13-8/h1-3,5H,4H2,(H,11,12)
153810-37-8Relevant articles and documents
ACYLHYDRAZONES AS KINASE MODULATORS
-
Page/Page column 51, (2010/11/24)
Abstract The invention is directed to acylhydrazones compounds of Formula I: where R1, R2 and A are as defined herein, the use of such compounds as protein tyrosine kinase modulators, particularly inhibitors of c-Met, and the use of such compounds to reduce or inhibit kinase activity of c-Met in a cell or a subject, and modulate c-Met expression in a cell or subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to c-Met. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as cancers and other cell proliferative disorders.
